These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Recombinant human erythropoietin plays a pivotal role as a topical stem cell activator to reverse effects of damage to the skin in aging and trauma. Bader A; Machens HG Rejuvenation Res; 2010 Aug; 13(4):499-500. PubMed ID: 20695821 [No Abstract] [Full Text] [Related]
46. [Preparation and cloning of hemopoietic factors and its clinical application. b. Erythropoietin]. Kawakita M Nihon Rinsho; 1987 Dec; 45(12):2775-82. PubMed ID: 3446873 [No Abstract] [Full Text] [Related]
47. Update on erythropoietin. Mason NA Am Pharm; 1994 Sep; NS34(9):16-8. PubMed ID: 7977020 [No Abstract] [Full Text] [Related]
48. Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration. Buemi M; Allegra A; Corica F; Floccari F; D'Avella D; Aloisi C; Calapai G; Iacopino G; Frisina N Nephrol Dial Transplant; 2000 Mar; 15(3):422-3. PubMed ID: 10692533 [No Abstract] [Full Text] [Related]
49. Does human recombinant erythropoietin improve wound healing? Roche RJ J Am Geriatr Soc; 1995 Jan; 43(1):81. PubMed ID: 7806748 [No Abstract] [Full Text] [Related]
50. Preoperative Anemia Correction in Cardiac Surgery: A Propensity-Matched Study. Ranucci M; Pavesi M; Pistuddi V; Baryshnikova E J Cardiothorac Vasc Anesth; 2021 Mar; 35(3):874-881. PubMed ID: 32741609 [No Abstract] [Full Text] [Related]
51. Can the cost of erythropoietin for cardiac surgery patients be justified? Strauss RG Transfusion; 1994 Sep; 34(9):835. PubMed ID: 8091475 [No Abstract] [Full Text] [Related]
52. [Application of erythropoietin to cardiovascular diseases]. Toba K; Ozawa T; Kato K Nihon Rinsho; 2011 Sep; 69 Suppl 7():533-6. PubMed ID: 22519047 [No Abstract] [Full Text] [Related]
53. Increase in endogenous erythropoietin synthesis through the normobaric oxygen paradox in cardiac surgery patients. Ciccarella Y; Balestra C; Valsamis J; Van der Linden P Br J Anaesth; 2011 May; 106(5):752-3. PubMed ID: 21498502 [No Abstract] [Full Text] [Related]
55. Do we perform better when we increase red blood cells? Perrey S Lancet Haematol; 2017 Aug; 4(8):e344-e345. PubMed ID: 28693986 [No Abstract] [Full Text] [Related]
56. [Application of recombinant human erythropoietin on cardiac surgery]. Hayashi J; Shinonaga M; Eguchi S; Shinada S Kokyu To Junkan; 1992 Aug; 40(8):751-7. PubMed ID: 1529171 [No Abstract] [Full Text] [Related]
57. [Treatment of anemia and stimulation of hematopoiesis in patients submitted to heart surgery with extracorporeal circulation]. Shevchenko IuL; Solov'eva NIu Vestn Khir Im I I Grek; 1998; 157(2):97-100. PubMed ID: 9691396 [No Abstract] [Full Text] [Related]
58. [Erythropoietin in the prevention and treatment of anemia in heart surgery patients]. Shevchenko IuL; Khubulava GG; Chechetkin AV; Belevitin AB; Solov'eva NIu Vestn Khir Im I I Grek; 1999; 158(6):69-71. PubMed ID: 10709275 [TBL] [Abstract][Full Text] [Related]
59. Acute treatment with recombinant erythropoietin in patients with pre- and postoperative anemia: a clinical report. von Bormann B; Weiler J; Aulich S Clin Investig; 1994; 72(6 Suppl):S31-5. PubMed ID: 7950170 [No Abstract] [Full Text] [Related]
60. [Effect of recombinant human erythropoietin on autologous blood pre-donation in open heart surgery]. Ono Y; Narita J; Takahashi S; Sawada M; Iwabuchi S; Tani A; Iwabuchi S; Shuto K; Fukui K; Kako N Kyobu Geka; 1991 Aug; 44(9):728-31. PubMed ID: 1956131 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]